How Old Do You Have to Be to Take Ozempic? What You Need to Know

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The FDA-approved Ozempic (semaglutide) carries different age requirements depending on whether it's prescribed for type 2 diabetes or chronic weight management. Understanding these guidelines helps you know whether you're a candidate for GLP-1 therapy and what to expect during your consultation with PlexusDx.

FDA Age Requirements for Semaglutide and Ozempic

Ozempic received FDA approval for type 2 diabetes treatment in adults 18 years and older, with no upper age limit. Wegovy, the weight-loss formulation of semaglutide, was approved in 2021 for chronic weight management in adults with a BMI of 30 or higher, or those with a BMI of 27 or higher with at least one weight-related condition. Both formulations require adult status—meaning you must be 18 years old—though clinical data supports safety across many age groups.

Pediatric use of semaglutide remains limited. In 2023, the FDA expanded Wegovy approval to include adolescents 12 years and older, but only under specific circumstances and with careful clinical oversight. This expansion followed pediatric trial data showing the medication reduced body weight in younger patients, though it also revealed important safety signals that require monitoring during treatment.

Medical Eligibility Beyond Age: BMI and Health Conditions

Age alone doesn't determine whether semaglutide is right for you. The FDA requires adults seeking weight-loss treatment to have either a BMI of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher plus a weight-related health condition such as type 2 diabetes, hypertension, or sleep apnea. These criteria reflect clinical evidence showing that GLP-1 therapy works best in people with metabolic risk factors rather than as a general weight-loss tool.

For type 2 diabetes management, semaglutide eligibility depends on blood glucose control needs rather than strict BMI thresholds. Adults of any weight can qualify if they have confirmed type 2 diabetes and need improved glycemic control. Your medical history, current medications, and kidney function also influence whether semaglutide is safe and appropriate for your individual situation.

How PlexusDx Assesses Your Candidacy for Compounded Semaglutide

PlexusDx serves adults seeking personalized GLP-1 therapy across all 50 states without requiring insurance. During your initial consultation, our clinical team reviews your age, BMI, medical history, and current medications to ensure semaglutide injections are appropriate for you. We follow FDA guidelines while also considering off-label use patterns supported by clinical evidence, always prioritizing your safety.

PlexusDx Compounded Semaglutide Injection starts at $149 per month and comes from licensed 503A compounding pharmacies. Unlike branded Ozempic, which carries significant out-of-pocket costs, our pricing remains flat across all dose levels—your dose may need to go up, but your price won't. This approach removes financial barriers while maintaining clinical oversight and quality standards.

Genetic Insights and Personalized Treatment at Any Age

Age influences how your body responds to semaglutide, but genetic variation plays an equally important role. PlexusDx offers the Precision Peptide Genetic Test, which analyzes key genetic variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313. These pathways affect how effectively your body responds to GLP-1 therapy, regardless of whether you're 25 or 75 years old.

The Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways and 150+ genetic insights, helping PlexusDx tailor your dose and medication choice for maximum results. Older adults with genetic predispositions toward insulin resistance may benefit from tirzepatide's dual-receptor action, while younger patients with specific GLP1R profiles might respond exceptionally well to semaglutide alone. Genetic testing removes guesswork from treatment personalization.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can you take semaglutide if you're under 18 years old?

The FDA approved Wegovy (semaglutide for weight loss) for adolescents ages 12 and older in 2023, but only under specialized clinical supervision. Semaglutide for type 2 diabetes remains restricted to adults 18 and older. PlexusDx specializes in adult treatment; if you're under 18, discuss GLP-1 options directly with your pediatrician or endocrinologist.

Is there an age limit for starting semaglutide treatment?

No upper age limit exists for semaglutide use. Clinical trials and real-world data support safety and effectiveness in adults over 65, though kidney function and other age-related health factors require evaluation. PlexusDx has successfully treated patients across all adult age groups with appropriate medical oversight.

What if I'm 18 but have a BMI under 27—can I still get semaglutide?

The FDA weight-loss indication requires a BMI of 30 or higher, or 27 with a weight-related condition like diabetes or hypertension. However, if you have type 2 diabetes, semaglutide qualifies regardless of BMI. PlexusDx evaluates your full medical picture during consultation to determine eligibility and the right medication for your situation.

Does age affect how quickly semaglutide works?

Age can influence medication metabolism and response timing. Older adults may experience slower dose escalation or need longer intervals between increases due to kidney function changes. PlexusDx personalizes your treatment timeline based on your age, health markers, and tolerance—ensuring safety without sacrificing effectiveness.

Can the Precision Peptide Genetic Test predict how well semaglutide will work based on my age?

The Precision Peptide Genetic Test identifies genetic variants affecting GLP-1 sensitivity independent of age. Your GLP1R and GIPR genotypes predict response likelihood, while age influences kidney clearance and dose tolerance. Together, these factors guide PlexusDx in selecting semaglutide, tirzepatide, or dual therapy for optimal personalized outcomes.

Related Reading

• Genetic Testing 101 What You Need To Know Before Getting Tested
• What Genetic Factors Determine How Much Sleep You Need Each Night
• Can Dna Tests Tell How Old You Are
• Lifemd Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.